TCL Archive In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS July 3, 1987
TCL Archive FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer September 24, 1999
TCL Archive In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH July 23, 1999
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
